viimane versioon :
29/10/2024
antibiootikum   Cefamandole nafate  
Süsteravim
Stabiilsus lahustes Stabiilsust mõjutavad tegurid stabiilsust mõjutavad faktorid Sobimatus Manustamis viis Viited pdf
   keemiline struktuur  

Kaubanduslikud nimed erinevates maades   Kaubanduslikud nimed erinevates maades     

Preparaatide nimed on näitlikud ja abianete sisaldus võib erineda sõltuvalt riigist ja laborist

Acemycin Kreeka
Cefam Itaalia, Ungari
Cefamandol Luksemburg
Cefamandolo Itaalia
Cemado Itaalia
Kefadol Iirimaa
Kefandol Maroko, Suurbritannia
Lampomandol Itaalia
Mancef Itaalia
Mandokef Austria, Itaalia, Kreeka, Sveits, Ungari
Mandol Araabia Ühendemiraadid, Austraalia, Holland, Luksemburg, uus-Meremaa
Mandolsan Itaalia
Septomandolo Itaalia
Tarcefandol Poola
Viited   Süsteravim   Viited : Cefamandole nafate  
tüüp avaldamine
198 ajaleht Gayed AA, Kheshary PR, Hinkle RL.
Visual compatibility of diltiazem injection with various diluents and medications during simulated Y-site injection.
Am J Health-Syst Pharm 1995 ; 52: 516-520.
336 ajaleht Forman JK, Lachs JR, Souney PF.
Visual compatibility of acyclovir sodium with commonly used intravenous drugs during simulated Y-site injection.
Am J Hosp Pharm 1987 ; 44: 1408-1409.
385 ajaleht Benedict MK, Roche VF, Banakar UV, Hilleman DE.
Visual compatibility of amiodarone hydrochloride with various antimicrobial agents during simulated Y-site injection.
Am J Hosp Pharm 1988 ; 45: 1117-1118.
405 ajaleht Nieves-Cordero AL, Luciw HM, Souney PF.
Compatibility of narcotic analgesic solutions with various antibiotics during simulated Y-site injection.
Am J Hosp Pharm 1985 ; 42: 1108-1109.
406 ajaleht Smythe MA, Patel MA, Gasloli RA.
Visual compatibility of narcotic analgesics with selected intravenous admixtures.
Am J Hosp Pharm 1990 ; 47: 819-820.
418 ajaleht Bosso JA, Townsend RJ.
Stability of clindamycin phosphate and ceftizoxime sodium, cefoxitine sodium, cefamandole nafate, or cefazolin sodium in two intravenous solutions.
Am J Hosp Pharm 1985 ; 42: 2211-2214.
472 ajaleht Wohlford JG, Fowler MD.
Visual compatibility of hetastarch with injectable critical-care drugs.
Am J Hosp Pharm 1989 ; 46: 995-996.
574 ajaleht Kleinberg ML, Stauffer GL, Prior RB, Latiolais CJ.
Stability of antibiotics frozen and stored in disposable hypodermic syringes.
Am J Hosp Pharm 1980 ; 37: 1087-1088.
576 ajaleht Holmes CJ, Ausman RK, Walter CW, Kundsin RB.
Activity of antibiotic admixtures subjected to different freeze-thaw treatments.
Drug Intell Clin Pharm 1980 ; 14: 353-357.
604 Labor Stabilité des médicaments dans l'Intermate® SV50, 100, 200
Baxter 1998
612 ajaleht Frable RA, Klink PR, Engel GL, Mundell EE.
Stability of cefamandole nafate injection with parenteral solutions and additives.
Am J Hosp Pharm 1982 ; 39: 622-627.
630 ajaleht Das Gupta V, Stewart KR.
Stability of metronidazole and ten antibiotics when mixed with magnesium sulphate solutions.
J Clin Hosp Pharm 1985 ; 10: 67-72.
999 ajaleht Watson D.
Piggyback compatibility of antibiotics with pediatric parenteral nutrition solution.
JPEN 1985 ; 9: 220-224.
1035 ajaleht Bisaillon S, Sarrazin R.
Compatibility of several antibiotics or hydrocortisone when added to metronidazole solution for intravenous infusion.
J Parenter Sci Technol 1983 ; 37: 129-132.
1047 ajaleht Souney PF, Colucci RD, Mariani G, Campbell D.
Compatibility of magnesium sulfate solutions with various antibiotics during simulated Y-site injection.
Am J Hosp Pharm 1984 ; 41: 323-324.
1057 ajaleht Cutie MR.
Compatibility of verapamil hydrochloride injection with commonly used additives.
Am J Hosp Pharm 1983 ; 40: 1205-1207.
1165 ajaleht Bowtle WJ, Heasman MJ, Prince AP, Easthope DA.
Compatibility of the cephalosporin, cefamandole nafate with injections.
Int J Pharm 1980 ; 4: 263-265.
1201 ajaleht Yuhas EM, Lofton FT, Rosenberg HA, Mayron D, Baldinus JG.
Cimetidine hydrochloride compatibility III: Room temperature stability in drug admixtures.
Am J Hosp Pharm 1981 ; 38: 1919-1922.
1232 ajaleht Beatson C, Taylor A.
A physical compatibility study of furosemide & flucloxacillin injections.
Br J Pharm Pract 1987 ; 9: 223-226, 236.
1479 ajaleht Digel S.
Cefamandolnafat und metronidazol. Chemische stabilität in einer mischung zur intravenösen infusion.
Krankenhauspharmazie 1995 ; 1: 9-12.
3520 Labor Cidomycin - Summary of product Chracteristics.
Sanofi 2011
3526 Labor Clindamycin (Dalacin®) - Summary of Product Characteristics
Pharmacia 2010
3546 Labor Cefamandole Flavelab - Résumé des caractéristiques du produit
Panpharma SA 2007
3549 Labor Amikacine B Braun - Résumé des caractéristiques du produit.
B Braun 2012
3594 Labor Metronidazole (Flagyl®) - Summary of Product Characteristics
Zentiva 2013
3643 Labor Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics
Sanofi 2015
3644 Labor Calcium gluconate® - Summary of Product Characteristics
Hameln Pharmaceuticals 2010
3674 Labor Erythromycin lactobionate - Summary of Product Characteristics
PanPharma 2016

  Mentions Légales